North America is leading market for Liquid Biopsy. Liquid biopsy market is on high growth in North America as colorectal cancer stands fourth most common diagnosed cancer in the region
North America Liquid Biopsy Market
PR-Inside.com: 2017-12-07 10:57:43
According to the report Liquid Biopsy Market, published by Market Data Forecast, the North America market is projected to reach USD 518.215 million by 2022, at a CAGR of 19.6% from 2017 to 2022.
Liquid biopsy is a medical test used to detect cancer cell in a blood sample. This helps to detect cancer at an early stage. Also this a non-invasive procedure, and hence easy to perform. Liquid biopsy also helps to monitor the efficiency of cancer treatment.
Get a comprehensive overview of the Liquid Biopsy Market: www.marketdataforecast.com/market-reports/north-america-liquid-b ..
Liquid Biopsy Market: Drivers & Restraints
Increasing incidence of cancer, growing demand for non-invasive surgery and government initiatives are primary factors driving the market growth. Also technological advancement and increasing funds for R&D are boosting the industry.
However, Reimbursement issues and regulatory policies are major factors hampering the market growth.
Get accurate market forecast and analysis on the Liquid Biopsy Market. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-reports/north-america-liquid-b ..
Liquid Biopsy Market: Segmentation
By Cancer Type
• Lung Cancer
• Pancreatic Cancer
• Other Visceral Cancers
By Sample Type
By Diagnostic Approach
• Circulating Tumour cells (CTC)
• Circulating Tumour DNA (ctDNA)
• RNA in exosomes
• Extra-Cellular Vesicles
By End Users
• Reference Laboratories
• Hospital/Physician Laboratories
• Academic and Research Centres
• Other End Users
• North America
o United States
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at www.marketdataforecast.com/market-reports/north-america-liquid-b ..
Liquid Biopsy Market: Overview
In the Cancer type segment, lung cancer category is expected to dominate the market during forecast period. In the Diagnostic Approach segment, Circulating Tumour cells category is expected to dominate the market during forecast period. Whereas in End Users segment, Cancer institute has the largest market share.
North America is expected to have the largest market share during forecast period owing to factors like advanced technologies and easy accessibility.
Liquid Biopsy Market: Key Players
The Liquid Biopsy market is highly competitive with a large number of players. Some of the major Companies are Janssen Diagnostics, Rarecells SAS, Silicon Biosystems and Qiagen. Other companies like Myriad Genetics, SRI International, Personal Genome Diagnostics, Sysmex Inostics, Natera, Trovagene, Exosome Sciences, Exosome Diagnostics and HansaBiomed OU.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ www.marketdataforecast.com/press-releases
Market Data Forecast
531/MIG-II, Rd Number 1, Kukatpally Housing Board Colony, Kukatpally, Hyderabad, Telangana 500072
# 548 Words